France Diabetes Devices Market Report (2024-2032) With Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
Medtronic: Hold Rating Justified by Financial Headwinds and Market Shifts
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $93
Medtronic Analyst Ratings
Medtronic Price Target Raised to $93 From $90 at Truist
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
